Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)

Clinical trial NCT01524783 · COMPLETED

Trial details

NCT number: NCT01524783
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced NET of GI Origin Advanced NET of Lung Origin Neuroendocrine Tumors

Start date: 2012-03-30
Primary completion: 2014-11-28
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.